Literature DB >> 34726305

Construction of Ni(CN)2 /NiSe2 Heterostructures by Stepwise Topochemical Pathways for Efficient Electrocatalytic Oxygen Evolution.

Jianwei Nai1, Xiangzhen Xu1, Qifan Xie1, Gongxun Lu1, Yao Wang1, Deyan Luan2, Xinyong Tao1, Xiong Wen David Lou2.   

Abstract

Exploiting effective electrocatalysts based on elaborate heterostructures for the oxygen evolution reaction (OER) has been considered as a promising strategy for boosting water splitting efficiency to produce the clean energy-hydrogen. However, constructing catalytically active heterostructures with novel composition and architecture remains poorly developed due to the synthetic challenge. In this work, it is demonstrated that unique Ni(CN)2 /NiSe2 heterostructures, composed of single-crystalline Ni(CN)2 nanoplates surrounded by crystallographically aligned NiSe2 nanosatellites, can be created from nickel-based Hofmann-type coordination polymers through stepwise topochemical pathways. When employed as the OER electrocatalyst, the Ni(CN)2 /NiSe2 heterostructures show enhanced performance, which could be attributed to optimized geometric and electronic structures of the catalytic sites endowed by the synergy between the two components. This work demonstrates a rational synthetic route for creating a novel Ni-based OER electrocatalyst that possesses nanoscale heterostructure, whose composition, spatial organization, and interface configuration can be finely manipulated.
© 2021 Wiley-VCH GmbH.

Entities:  

Keywords:  electrocatalysts; heterostructures; nanostructures; oxygen evolution reaction; topochemical reactions

Year:  2021        PMID: 34726305     DOI: 10.1002/adma.202104405

Source DB:  PubMed          Journal:  Adv Mater        ISSN: 0935-9648            Impact factor:   30.849


  1 in total

Review 1.  Nanoscale hetero-interfaces for electrocatalytic and photocatalytic water splitting.

Authors:  Baopeng Yang; Dingzhong Luo; Shimiao Wu; Ning Zhang; Jinhua Ye
Journal:  Sci Technol Adv Mater       Date:  2022-10-04       Impact factor: 7.821

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.